Fresenius Medical Care


More difficult home turf

12/08/19 -"We have become more cautious regarding the future payment systems in the US. The adjustments in the past had been more precise and transparent in our view. The sluggish disclosure of relevant ..."

Pages
48
Language
English
Published on
12/08/19
You may also be interested by these reports :
16/08/19
Healthineers has announced the acquisition of Corindus Vascular Robotics, a US-based medtech company, for an EV of USD1.1bn. Closing is expected in ...

16/08/19
Valuation Wise takes a rest over 12-16 August. Below is a piece that was issued on 7 August 2019. The case remains intact. Health ex Pharma (a motley ...

12/08/19
We have become more cautious regarding the future payment systems in the US. The adjustments in the past had been more precise and transparent in our ...

12/08/19
Sales momentum accelerated significantly in Q3 led by broad-based growth across the ophthalmology segment, particularly in Asia. Growth in adjusted ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO